Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity

The antiangiogenic agent bevacizumab showed synergistic effects when combined with chemotherapy in advanced breast cancer. We presently investigated the activity of bevacizumab in combination with chemotherapy, including capecitabine and vinorelbine, and endocrine therapy, including letrozole (+trip...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Torrisi, R, Bagnardi, V, Cardillo, A, Bertolini, F, Scarano, E, Orlando, L, Mancuso, P, Luini, A, Calleri, A, Viale, G, Goldhirsch, A, Colleoni, M
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2008
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2584958/
https://ncbi.nlm.nih.gov/pubmed/18941458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604741
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares